文献类型：期刊文献

英文题名：Validation Status of Electronic Sphygmomanometers in China: A National Survey

作者：Zhang, Xianghui[1,2];Xu, Zhimin[3];Yao, Yingchun[4];Zheng, Huilei[5];Wu, Jian[6];Hu, Jingwen[7];Wu, Shenggen[8];Lyu, Quanjun[9];Liu, Yong[10];Wu, Min[11];Chen, Liangxia[12];Xu, Lina[13];Zhou, Haiyan[14];Duan, Peifen[15];Dai, Jianghong[16];Ding, Hong[17];Wang, Shuang[18];Zhao, Yi[19];Hu, Jihong[20];Zhu, Liyue[21];Hai, Rong[22];Zhong, Baoliang[23];Zhu, Huilian[24];Li, Kui[25];Lu, Yao[26];Tang, Shaowen[27];Li, Xingming[28];Zhang, Yan[29];Chen, Zongtao[30];Wang, Tongyu[31];Li, Mei[32];Liu, Fuxu[33];Liu, Chengluan[34];Yang, Xiaoling[35];Dong, Lihua[36];Ma, Jixiang[12];Gao, Pei[37];Xie, Wuxiang[2];Wu, Yangfeng[2,37,38]

第一作者：Zhang, Xianghui

通信作者：Wu, YF[1]

机构：[1]Shihezi Univ, Dept Prevent Med, Shihezi, Xinjiang, Peoples R China;[2]Peking Univ, Inst Adv Clin Med, Clin Res Inst, 38 Xueyuan Rd, Beijing 100038, Peoples R China;[3]Shanghai Jiao Tong Univ, Xinhua Hosp Affiliated, Dept Cardiol, Sch Med, Shanghai, Peoples R China;[4]Sichuan Univ, West China Hosp, Dept Outpatient, Chengdu, Peoples R China;[5]Guangxi Med Univ, Affiliated Hosp 1, Dept Hlth Management, Nanning, Peoples R China;[6]Harbin Med Univ, Affiliated Hosp 2, Cardiac Rehabil Ctr, Dept Cardiol, Harbin, Heilongjiang, Peoples R China;[7]Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiol, Xian, Shaanxi, Peoples R China;[8]Fujian Prov Ctr Dis Control & Prevent, Emergency Response Inst, Fuzhou, Fujian, Peoples R China;[9]Zhengzhou Shuqing Med Coll, Dept Publ Hlth, Zhengzhou, Henan, Peoples R China;[10]Nanchang Univ, Sch Publ Hlth, Nanchang, Jiangxi, Peoples R China;[11]Dongguan St Community Hlth Serv Ctr, Gen Practice Clin, Beijing, Qinghai, Peoples R China;[12]Shandong Ctr Dis Control & Prevent, Hlth Management Inst, Beijing, Peoples R China;[13]Guizhou Ctr Dis Control & Prevent, Inst Chron Dis Prevent & Control, Guiyang, Peoples R China;[14]Hainan Med Univ, Affiliated Hosp 1, Dept Clin Nutr, Haikou, Peoples R China;[15]Changzhi Med Coll, Dept Publ Hlth & Prevent Med, Changzhi, Shanxi, Peoples R China;[16]Xinjiang Med Univ, Sch Publ Hlth, Urumqi, Peoples R China;[17]Anhui Med Univ, Sch Hlth Serv Management, Hefei, Peoples R China;[18]China Med Univ, Hosp 1, Dept Gen Practice, Shenyang, Liaoning, Peoples R China;[19]Ningxia Med Univ, Sch Publ Hlth, Yinchuan, Peoples R China;[20]Gansu Univ Chinese Med, Sch Publ Hlth, Lanzhou, Peoples R China;[21]Zhejiang Hosp, Dept Cardiac Rehabil, Hangzhou, Peoples R China;[22]Inner Mongolia Univ, Biomed Res Inst, Hohhot, Peoples R China;[23]Wuhan Mental Hlth Ctr, Dept Psychiat, Wuhan, Hubei, Peoples R China;[24]Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China;[25]Tibet Autonomous Reg Peoples Hosp, Dept Cardiol, Lhasa, Xizang, Peoples R China;[26]Cent South Univ, Xiangya Hosp 3, Clin Res Ctr, Changsha, Hunan, Peoples R China;[27]Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China;[28]Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China;[29]Baoding Ctr Dis Control & Prevent, Dept Chron Noncommunicable Dis Prevent & Control, Beijing, Hebei, Peoples R China;[30]Third Mil Med Univ, Army Med Univ, Hlth Management Ctr, Affiliated Hosp 1, Chongqing, Peoples R China;[31]Peking Univ, Care Chinese Natl Offshore Oil Corp Hosp, Dept Neurol, Tianjin, Peoples R China;[32]Hebei Prov Ctr Dis Control & Prevent, Dept Chron Noncommunicable Dis Prevent & Control, Shijiazhuang, Peoples R China;[33]Jilin Prov First Automobile Works Gen Hosp, Dept Emergency, Changchun, Peoples R China;[34]Fuwai Yunan Cardiovasc Hosp, Dept Cardiol, Yunnan, Peoples R China;[35]Baoshan Peoples Hosp, Dept Cardiol, Baoshan, Yunnan, Peoples R China;[36]Tengchong Peoples Hosp, Dept Obstet & Gynecol, Tengchong, Yunnan, Peoples R China;[37]Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China;[38]Peking Univ, State Key Lab Vasc Homeostasis & Remodeling, Beijing, Peoples R China

第一机构：Shihezi Univ, Dept Prevent Med, Shihezi, Xinjiang, Peoples R China

通信机构：[1]corresponding author), Peking Univ, Inst Adv Clin Med, Clin Res Inst, 38 Xueyuan Rd, Beijing 100038, Peoples R China.

年份：2025

卷号：82

期号：3

起止页码：532

外文期刊名：HYPERTENSION

收录：;Scopus(收录号：2-s2.0-85216232970);WOS:【SCI-EXPANDED(收录号:WOS:001424695400005)】；

基金：The study was supported and organized by the Health Risk Assessment and Control Committee of the Chinese Preventive Medicine Association

语种：英文

外文关键词：blood pressure; blood pressure monitors; cross-sectional survey; device approval; sphygmomanometers; validation studies as topic

摘要：BACKGROUND: Although the information on the validation status of electronic sphygmomanometer (ES) devices in use in health care institutions and households is much more clinically relevant than that of ES models available on the market, it remains insufficient. METHODS: A national survey was conducted across all administrative regions of mainland China to assess the validation status of ESs. Fifty-eight cities were selected with stratification by municipality, provincial capital, and other cities, and health care institutions and households in each city were chosen by convenience to identify ES devices in use according to the study protocol. Information on devices' model, type, was collected. The validation status of each device was ascertained through searching international online registries of its models. RESULTS: A total of 3230 ES devices (1924 from health care institutions and 1306 from households), encompassing 498 ES models, were actually selected. The weighted proportion of accuracy-validated devices was significantly higher in health care institutions (33.9% [95% CI, 31.8-36.0%]) compared with households (23.0% [95% CI, 20.8-25.4%]; P<0.001), and both exceeded the proportions for models (17.7% [95% CI, 13.7-22.6%] and 12.5% [95% CI, 9.5-16.3%], respectively). Regional economic development, device type, and years in use were associated with the proportion of accuracy-validated devices. Notably, 8.8% of devices used in secondary hospitals were wrist type. CONCLUSIONS: The accuracy validation status of ESs in China in the number of devices in use shows a more favorable situation than that in the number of models but remains low and concerning. Policies are urgently needed to promote the widespread adoption of accuracy-validated models among all users.